Iowa House Bill HSB19

Iowa 2025-2026 Regular Session

• Introduced: 1/15/25
• Refer: 1/15/25

Caption

A bill for an act relating to prior authorizations and exemptions by health benefit plans and utilization review organizations.(See HF 303.)

Impact

This bill could have a significant impact on state laws regarding health insurance and provider operations. By enforcing stricter timelines for responses from utilization review organizations, the bill intends to improve timeliness in healthcare delivery. Additionally, the requirement for annual reviews of prior authorization practices aims to eliminate redundant authorization requirements that do not promote improved healthcare quality or cost-effectiveness. Consequently, this change signifies a shift towards enhancing patient care by reducing the bureaucratic hurdles that often accompany healthcare provision.

Summary

House Study Bill 19 relates to the process of prior authorizations imposed by health benefit plans and the utilization review organizations in Iowa. The bill mandates that by January 15, 2026, all health carriers that provide health benefit plans must implement a pilot program that grants exemptions from certain prior authorization requirements for a subset of providers, specifically targeting primary health care providers. The bill aims to streamline healthcare access and reduce administrative burdens by eliminating unnecessary red tape, making it easier for healthcare providers to deliver care without extensive delays due to prior authorization processes.

Contention

While the intent of HSB19 is to facilitate better access to healthcare, some stakeholders might raise concerns regarding the implementation of this exemption program. Potential issues include the criteria set by health carriers for exemptions and how they may be interpreted. Furthermore, the mechanics of reporting results to the commissioner of insurance may lead to debate around compliance and oversight. Critics may express that the provisions could still leave loopholes for insurance companies to exploit, thereby not fully achieving the intended relief for healthcare providers and patients.